These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35294390)

  • 21. Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review.
    Aderoba AK; Steyn PS; Kiarie JN
    Syst Rev; 2023 Jul; 12(1):114. PubMed ID: 37403147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects.
    Liu J; Shen J; Diamond-Smith N
    Contraception; 2018 Nov; 98(5):430-437. PubMed ID: 29733817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
    Dragoman MV; Gaffield ME
    Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results.
    Okegbe T; Affo J; Djihoun F; Zannou A; Hounyo O; Ahounou G; Bangbola KA; Harris N
    Glob Health Sci Pract; 2019 Jun; 7(2):228-239. PubMed ID: 31171559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Young Women's Experiences With Subcutaneous Depot Medroxyprogesterone Acetate: A Secondary Analysis of a One-Year Randomized Trial in Malawi.
    Burke HM; Chen M; Packer C; Fuchs R; Ngwira B
    J Adolesc Health; 2020 Nov; 67(5):700-707. PubMed ID: 32389457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa.
    Bertrand JT; Bidashimwa D; Makani PB; Hernandez JH; Akilimali P; Binanga A
    Contraception; 2018 Nov; 98(5):411-417. PubMed ID: 30120925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of job aids on knowledge retention among Patent and Proprietary Medicine Vendors trained to administer injectable contraceptives: longitudinal results from implementation science in Nigeria.
    Chace Dwyer S; Jain A; Ishaku SM; Okunade FT; Uzomba C; Adebayo A; Tobey E
    BMC Public Health; 2019 Oct; 19(1):1362. PubMed ID: 31651273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate.
    Curtis KM; Nguyen A; Reeves JA; Clark EA; Folger SG; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):739-743. PubMed ID: 34014910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
    Smith TJ; Urdanigo TK; Shroff N; Rubin SE
    Contraception; 2023 Jul; 123():110008. PubMed ID: 36931548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Pilot Study of Adolescent and Young Adult Experience with Subcutaneous Depot Medroxyprogesterone Acetate.
    Wernick HJ; Wentzel E; Jackson K; Schmuhl K; Valenti O; Bonny AE; Berlan ED
    J Pediatr Adolesc Gynecol; 2023 Dec; 36(6):549-552. PubMed ID: 37354986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study.
    Burke HM; Packer C; Zingani A; Moses P; Bernholc A; Ruderman LW; Martinez A; Chen M
    PLoS One; 2022; 17(10):e0275986. PubMed ID: 36256638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood.
    Kohn JE; Simons HR; Della Badia L; Draper E; Morfesis J; Talmont E; Beasley A; McDonald M; Westhoff CL
    Contraception; 2018 Mar; 97(3):198-204. PubMed ID: 29246818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-injected contraceptives: does the investment reflect women's preferences?
    Wood SN; Magalona S; Zimmerman LA; OlaOlorun F; Omoluabi E; Akilimali P; Guiella G; Gichangi P; Anglewicz P
    BMJ Glob Health; 2022 Jul; 7(7):. PubMed ID: 35835480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot-Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era.
    Osinowo K; Sambo-Donga F; Ojomo O; Ibitoye SE; Oluwayemi P; Okunfulure M; Ladipo OA; Ekholuenetale M
    Open Access J Contracept; 2021; 12():187-199. PubMed ID: 34880691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Katz M; Newmark RL; Aronstam A; O'Grady N; Strome S; Rafie S; Karlin J
    Contraception; 2020 Dec; 102(6):392-395. PubMed ID: 32931811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda.
    Odwe G; Gray K; Kyarimpa A; Obare F; Nagendi G
    Glob Health Sci Pract; 2018 Dec; 6(4):711-722. PubMed ID: 30429201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adolescent and covert family planning users' experiences self-injecting contraception in Uganda and Malawi: implications for waste disposal of subcutaneous depot medroxyprogesterone acetate.
    Burke HM; Packer C; Wando L; Wandiembe SP; Muwereza N; Pradhan S; Zingani A; Ngwira B
    Reprod Health; 2020 Aug; 17(1):117. PubMed ID: 32746860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
    Comfort AB; Alvarez A; Goodman S; Upadhyay U; Mengesha B; Karlin J; Shokat M; Blum M; Harper CC
    Contraception; 2024 Mar; 131():110360. PubMed ID: 38158075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women.
    Williams RL; Hensel DJ; Fortenberry JD
    Contraception; 2013 Sep; 88(3):401-7. PubMed ID: 23294549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
    Cameron ST; Glasier A; Johnstone A
    Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.